Advertisement

Indoco Remedies gets USFDA nod for blood thinning drug

Follow The Hawk on Google News+ Follow

Advertisement


New Delhi: Drug firm Indoco Remedies on Monday said it has received approval from the US health regulator for blood thinning drug Apixaban tablets.

The approved product is therapeutically equivalent to the reference listed drug Eliquis of Bristol-Myers Squibb.

Advertisement

In a regulatory filing, Indoco Remedies said it has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Apixaban tablets in the strengths of 2.5 mg and 5 mg.

Also readFSSAI to initiate action against Bisleri over unsafe water sample

Apixaban is an anticoagulant, or blood thinner. It is used for patients with health problems caused by a blood clot.

Quoting IMS June 2020 moving annual total data, Indoco Remedies said the US market size of Apixaban tablets is USD 11,037 million.

Shares of Indoco Remedies were trading 3.50 per cent higher at Rs 228.95 apiece on BSE. —PTI

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST